Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research How To Prevent Failure in Rare Disease Trials?
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research How To Prevent Failure in Rare Disease Trials?
